Turn Therapeutics Inc.
NASDAQ:TTRXBiotechnology
Healthcare
$8.64 -2.79%
-$0.17 today
- Market cap
- $264.15M
- Beta
- 2.77
- P/E (TTM)
- -45.0
- EPS (TTM)
- -$0.13
52W Low $2.57High $26.50
Volume 0.13M
Average 0.04M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$5.86M
FY 2025 · Annual
Net Income
-$3.19M
FY 2025 · Annual
Income Statement
USD
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Gross Margin | — | — | — |
| Research & Development | 7.5K | 245.96K | 265.57K |
| Selling, General & Admin | 2.3M | 1.55M | 5.59M |
| Operating Expenses | 2.31M | 1.8M | 5.86M |
| Depreciation & Amortization | 43.92K | 47.48K | 52.75K |
| EBITDA | (2.25M) | (1.72M) | (3.14M) |
| EBITDA Margin | — | — | — |
| Operating Income | (2.31M) | (1.8M) | (5.86M) |
| Operating Margin | — | — | — |
| Interest Income | 15.88K | 28.71K | 29.58K |
| Interest Expense | 0 | 0 | 0 |
| Other Income / Expenses | 15.88K | 28.71K | 2.66M |
| Income Before Tax | (2.29M) | (1.77M) | (3.19M) |
| Pre-Tax Margin | — | — | — |
| Income Tax Expense | 0 | 0 | 0 |
| Net Income | (2.29M) | (1.77M) | (3.19M) |
| Net Margin | — | — | — |
| EPS (Basic) | (0.17) | (0.13) | (0.23) |
| EPS (Diluted) | (0.17) | (0.13) | (0.23) |
| 13.25M | 13.42M | 13.74M | |
| 13.25M | 13.42M | 13.74M |
TTRX Earnings Waterfall · TTM
NASDAQ:TTRX · Revenue to Net Income
Key Ratios
EPS$-0.18
Gross Margin0.0%
Net Margin0.0%
P/E Ratio8.6
P/S Ratio0.0
Analysis
$0 of revenue converted into -$3.8M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.18, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 10, 2026 | |
| S-3 | S-3 filing | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| S-3 | S-3 filing | Nov 9, 2026 |
How much revenue does TTRX generate?
Turn Therapeutics Inc. (TTRX) reported $0.00 of revenue in fiscal 2025.
Is TTRX profitable?
Turn Therapeutics Inc. (TTRX) reported -$3.19M of net income.
Continue the stock analysis
Jump to another research area for this company.